Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111533662B details a cost-effective synthesis of citalopram intermediates using accessible halogenated benzoic acids, offering significant supply chain advantages.
Patent CN101395165A discloses a high-efficiency asymmetric ligand enabling cost reduction in pharmaceutical intermediate manufacturing with superior enantioselectivity.
Patent CN114105772B details a high-yield synthesis route for 2-chloro-4-fluoro-5-nitrobenzoic acid offering significant supply chain stability and cost optimization for global buyers.
Patent CN111689912A reveals a metal-free g-C3N4 photocatalytic route for quinoxalinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111285768B introduces a recyclable polyionic liquid copper catalyst for efficient asymmetric Henry reactions in water, offering significant cost reduction in chiral catalyst manufacturing.
Patent CN103044415A details a novel acyl chloride route for Aztreonam, eliminating strong acid damage and enhancing purity for reliable pharmaceutical intermediate supply chains.
Patent CN107501156B details a one-pot synthesis for 2-cyano-3-arylpyrroles. This method offers significant cost reduction in API manufacturing and high-purity intermediates.
Patent CN104177357B details a Rh-catalyzed isoquinoline salt synthesis using oxygen. This method offers high purity, cost reduction, and scalable manufacturing for pharmaceutical intermediates.
Novel copper-catalyzed room temperature method for high-purity pharmaceutical intermediates ensuring cost reduction and supply chain reliability.
Patent CN101633647B details a novel four-step synthesis for alpha-azyl aryl alkyl ketones, offering superior yield and purity for reliable pharmaceutical intermediate supply chains.
Novel low-cost preparation of esomeprazole magnesium via asymmetric oxidation. Optimized for industrial scale-up and supply chain stability.
Novel metal-free one-pot synthesis of 2-methylthio-maleic diesters offers high yield and cost reduction for pharmaceutical manufacturing supply chains.
Patent CN112573978A reveals a high-yield sulfoxide-catalyzed halogenation method offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Novel synthetic route for Febuxostat intermediates ensuring high purity and scalable production for global pharmaceutical supply chains reducing costs significantly and enhancing safety protocols.
Patent CN112876507B details a Ru-catalyzed hydroarylation method for trisubstituted olefin phosphines, offering high yields up to 90% and reduced costs for pharma intermediates.
Patent CN110714002B discloses a highly efficient nitrilase mutant for synthesizing (S)-3-cyano-5-methylhexanoic acid, offering superior stereoselectivity and solubility for scalable pharmaceutical manufacturing.
Patent CN115925609A details a green FeCl2-catalyzed route to 3-alkenyl oxindoles. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN112794837B reveals a high-yield isochroman synthesis using TPSCA. This method offers mild conditions and cost reduction in pharmaceutical intermediate manufacturing.
Improved olanzapine preparation method patent CN103848847B offers high purity and solvent recycling for cost-effective pharmaceutical intermediate manufacturing supply chain optimization and reliability.
Patent CN115448841A reveals a cost-effective silver-catalyzed method for synthesizing primary amines using ammonia water, offering significant advantages for pharmaceutical intermediate manufacturing.